Ablation Devices Market Report – Research, Industry Analysis Reports and Market Demands

Ablation Devices Global Market

Request for Sample of this report

Buy now

Table of Content

1 EXECUTIVE SUMMARY 22

2 INTRODUCTION 29

2.1 KEY TAKE AWAYS 29
2.2 REPORT DESCRIPTION 30
2.3 MARKETS COVERED 31
2.4 STAKEHOLDERS 34
2.5 RESEARCH METHODOLOGY 34
- 2.5.1 MARKET SIZE ESTIMATION 35
- 2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION 38
- 2.5.3 SECONDARY SOURCES 39
- 2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 40
- 2.5.5 PRIMARY SOURCES 40
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 41
- 2.5.7 ASSUMPTIONS 41

3 MARKET ANALYSIS 43

3.1 INTRODUCTION 43
3.2 MARKET SEGMENTATION 44
3.3 FACTORS INFLUENCING MARKET 46
- 3.3.1 DRIVERS AND OPPORTUNITIES 47
  - 3.3.1.1 Increasing Aging Population 47
  - 3.3.1.2 Rising Incidence of Cancer and Cardiovascular Diseases 47
  - 3.3.1.3 Growing Adoption of Minimally Invasive Procedures 48
  - 3.3.1.4 Improving Reimbursement Scenario In Established Markets 49
  - 3.3.1.5 Emergence of Next-Generation Ablation Products and Technologies 51
  - 3.3.1.6 Increasing Number of Ablation Procedures 52
  - 3.3.1.7 Increasing Funding for the Development of Novel Ablation Device 53
  - 3.3.1.8 Emerging APAC Markets 54
- 3.3.2 RESTRAINTS & THREATS 55
  - 3.3.2.1 Reuse And Reprocessing of Devices in Developing Countries 55
  - 3.3.2.2 Healthcare Cost Containment Measures 56
  - 3.3.2.3 Stringent Regulatory Approvals 56
  - 3.3.2.4 Challenges in Therapeutic Procedures 57
3.4 UPCOMING TECHNOLOGY 58
3.5 REIMBURSEMENT 68
3.6 REGULATORY AFFAIRS 74
- 3.6.1 U.S. 75
- 3.6.2 EUROPE 75
- 3.6.3 INDIA 76
- 3.6.4 CHINA 77
- 3.6.5 JAPAN 78
3.7 PATENT TRENDS 78
3.8 SUPPLY CHAIN ANALYSIS 80
3.9 PORTER’S FIVE FORCE ANALYSIS 83
- 3.9.1 THREAT OF NEW ENTRANTS 84
- 3.9.2 THREAT OF SUBSTITUTES 85
- 3.9.3 BARGAINING POWER OF SUPPLIERS 86
- 3.9.4 BARGAINING POWER OF BUYERS 86
- 3.9.5 RIVALRY AMONG EXISTING COMPETITORS 86
3.10 MARKET SHARE ANALYSIS 88
- 3.10.1 MARKET SHARE ANALYSIS BY ABLATION DEVICE MAJOR PLAYERS 88
- 3.10.2 MARKET SHARE ANALYSIS BY ATRIAL FIBRILLATION ABLATION DEVICE MAJOR PLAYERS 92
- 3.10.3 MARKET SHARE ANALYSIS BY RADIATION ABLATION DEVICE MAJOR PLAYERS 94

4 ABLATION DEVICES GLOBAL MARKET, BY TECHNOLOGY 96

4.1 INTRODUCTION 96
4.2 THERMAL ABLATION 99
- 4.2.1 RADIOFREQUENCY ABLATION 104
- 4.2.2 LASER ABLATION TECHNOLOGY 110
- 4.2.3 MICROWAVE ABLATION TECHNOLOGY 114
- 4.2.4 ULTRASOUND ABLATION TECHNOLOGY 118
- 4.2.5 RADIATION ABLATION TECHNOLOGY 125
- 4.2.6 CRYOABLATION TECHNOLOGY 130
- 4.2.7 HYDROTHERMAL ABLATION TECHNOLOGY 133
4.3 NON-THERMAL TECHNOLOGY BASED ABLATION 136
- 4.3.1 ELECTROPORATION ABLATION TECHNOLOGY 141
- 4.3.2 MECHANICAL ABLATION TECHNOLOGY 142
- 4.3.3 OTHERS 146

5 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION 148

5.1 INTRODUCTION 148
5.2 ONCOLOGY 150
5.3 CARDIOVASCULAR 154
- 5.3.1 ATRIAL FIBRILATION (AF/AFIB) 157
- 5.3.2 VENTRICULAR TACHYCARDIA (VT) 159
- 5.3.3 OTHERS 161
5.4 OPHTHALMOLOGY 164
5.5 COSMETOLOGY 166
5.6 GYNECOLOGY 168
5.7 GENERAL SURGERY 171
5.8 UROLOGY 173
5.9 ORTHOPEDICS 176
5.10 PAIN MANAGEMENT 178
5.11 OTHER 180

6 ABLATION DEVICES GLOBAL MARKET, BY END-USERS 182

6.1 INTRODUCTION 182
6.2 HOSPITALS 184
6.3 AMBULATORY SURGICAL CENTRES 186
6.4 SPECIALITY CLINICS 188

7 REGIONAL MARKET ANALYSIS 190

7.1 INTRODUCTION 190
7.2 NORTH AMERICA 192
- 7.2.1 U.S. 200
- 7.2.2 OTHERS 203
7.3 EUROPE 205
- 7.3.1 U.K. 213
- 7.3.2 GERMANY 216
- 7.3.3 FRANCE 217
- 7.3.4 OTHERS 219
7.4 ASIA PACIFIC 221
- 7.4.1 INDIA 229
- 7.4.2 CHINA 231
- 7.4.3 JAPAN 234
- 7.4.4 OTHERS 236
7.5 REST OF THE WORLD 238
- 7.5.1 MIDDLE EAST 246
- 7.5.2 BRAZIL 248
- 7.5.3 OTHERS 250

8 COMPANY DEVELOPMENTS 253

8.1 INTRODUCTION 253
- 8.1.1 MERGER AND ACQUISITION AS A MAJOR GROWTH STRATEGY OF ABLATION DEVICE MARKET PLAYERS 254
8.2 MERGERS AND ACQUISITIONS 254
8.3 APPROVAL 258
8.4 NEW PRODUCT LAUNCH 262
8.5 AGREEMENTS PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 265
8.6 BUSINESS EXPANSION 266

9 MAJOR PLAYER PROFILES 268

Description

Ablation is the minimally invasive therapeutic tissue excision procedure used for a wide range of purposes, from cancerous or diseased tissue removal, to the removal of abnormally conducting cardiac tissue in atrial fibrillation and others. The growing adoption of minimally invasive procedures is pushing the researchers to innovate and improvise existing ablation technologies for better patient care.
The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023. The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023.
By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023.
By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023
By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market.
The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.
The ablation device global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the ablation device global market include Boston Scientific Corporation (U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan), ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.), Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Buy now